Sold as Fortaz In Plastic Container. Every FDA application for this active ingredient: 1 branded and 1 generic.
As of Nov 15, 2026, FDA lists 2 applications for Ceftazidime Sodium (sold as Fortaz In Plastic Container), first approved Apr 28, 1989, with 0 new uses approved and 0 published complete response letters.
| Ceftazidime Safety and Efficacy in the Prevention of Surgical Site InfectionsThoracolumbar Spinal Fusion · University of Utah | Phase 2 | Enrolling by invitation | Nov 12, 2026 |
| Aztreonam-Avibactam in Immunocompromised HostsEnterobacteriaceae Infections, Carbapenem-Resistant Enterobacteriaceae Infection · Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno | — | Recruiting | Oct 22, 2026 |
| Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaHospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP) · Wockhardt | Phase 3 | Not yet recruiting | Oct 21, 2026 |
| Restrictive Versus Standard Antibiotic Treatment During CAR-T TherapyLarge B-Cell Lymphoma (LBCL), Multiple Myeloma (MM) · Zealand University Hospital | Phase 2 | Not yet recruiting | Sep 25, 2026 |
| This is a Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ertapenem-zidebactam Versus Ceftazidime-Avibactam in the Treatment of Hospitalized Adult Patients With Complicated Urinary Tract Infection or Acute PyelonephritisComplicated Urinary Tract Infections(cUTI), Acute Pyelonephritis · Wockhardt | Phase 2 | Not yet recruiting | Sep 24, 2026 |
| Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver TransplantationLiver Transplant, Carbapenem-resistant Enterobacterales · IRCCS Azienda Ospedaliero-Universitaria di Bologna | Phase 3 | Not yet recruiting | Aug 12, 2026 |
| Ceftazidime-Avibactam PK/PD and Resistance in Hematology PatientsHematologic Neoplasms, Gram-Negative Bacterial Infections · Sizhou Feng | — | Not yet recruiting | Jul 14, 2026 |
| INterest of the Negative Predictive Value of Integrons in the reduCtion of Large Broad-spectrum anTibiotics Consumption for Urinary Tract infectionSDrug Resistance, Microbial, Biomarkers · University Hospital, Limoges | Not applicable | Recruiting | Jun 30, 2026 |
| Apr 28, 1989 | Fortaz In Plastic ContainerNDA 50634 · New dosage form | Pai Holdings Pharm | 21 | Discontinued |
| Apr 29, 1993 | Ceftazidime Sodium In Plastic ContainerANDA 63221 | Baxter Hlthcare | 3 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Baxter Hlthcare